Pang B, Dettmer M, Ong C W, Dhewar A N, Gupta S, Lim G L, Nga M E, Seet J E, Qasim A, Chin T M, Soo R, Soong R, Salto-Tellez M
Cancer Science Institute, National University of Singapore, Singapore City, Singapore.
Cytopathology. 2012 Aug;23(4):229-36. doi: 10.1111/j.1365-2303.2012.01000.x.
To compare the rejection rates of non-small cell lung cancer (NSCLC) samples obtained by differing sampling methods for testing by Sanger sequencing for epidermal growth factor receptor (EGFR) mutations. To assess the association between unsatisfactory outcomes and the quantity of DNA extracted from cytological versus histological samples.
Six hundred and seventy NSCLC samples referred to our centre from 2008 to 2010 were reviewed as a consequence of sample rejection, presence of EGFR mutations, cytological versus histological sampling methods, DNA quantity and the unsatisfactory genotyping rate.
Eighty samples were rejected for testing in similar proportions of histological and cytological samples (11.9% versus 10.9%) usually (n = 75) because the amount of cellular material was judged insufficient in small biopsies or cytology samples. The remaining 590 samples on which EGFR testing was attempted yielded 51 (8.6%) unsatisfactory test outcomes caused by failure of the polymerase chain reaction (PCR) (n = 47 cases), uninterpretable Sanger chromatograms (n = 3 cases) and insufficient DNA extracted for PCR (n = 1 case). The difference in rates of unsatisfactory outcomes between cytological samples (seven of 147 samples or 4.7%) versus tissue samples (44 of 443 samples or 9.9%) was clinically relevant but not statistically significant (Mann-Whitney test; P < 0.081). There was no association between the concentration of DNA extracted and the likelihood of an unsatisfactory analysis; which was similar in all types of sections (large and small) while 0% of 37 cytology slides were unsatisfactory.
Utilizing cytology samples for EGFR testing avoids unnecessary patient re-biopsing and yields a clinically superior satisfactory rate to the overall satisfactory rate of tissue biopsies of NSCLC. The quality rather than quantity of DNA extracted may be a more important determinant of a satisfactory result.
比较通过不同采样方法获取的非小细胞肺癌(NSCLC)样本,采用桑格测序法检测表皮生长因子受体(EGFR)突变时的拒收率。评估不满意结果与从细胞学样本和组织学样本中提取的DNA数量之间的关联。
回顾了2008年至2010年转至本中心的670例NSCLC样本,涉及样本拒收情况、EGFR突变情况、细胞学与组织学采样方法、DNA数量以及不满意基因分型率。
80份样本被拒收用于检测,组织学样本和细胞学样本的拒收比例相似(11.9%对10.9%),通常(n = 75)是因为在小活检或细胞学样本中判断细胞材料量不足。其余590份尝试进行EGFR检测的样本产生了51份(8.6%)不满意检测结果,原因是聚合酶链反应(PCR)失败(n = 47例)、桑格色谱图无法解读(n = 3例)以及提取的DNA不足以进行PCR(n = 1例)。细胞学样本(147份样本中的7份或4.7%)与组织样本(443份样本中的44份或9.9%)的不满意结果发生率差异具有临床相关性,但无统计学意义(曼-惠特尼检验;P < 0.081)。提取的DNA浓度与不满意分析的可能性之间无关联;在所有类型的切片(大切片和小切片)中情况相似,而37份细胞学载玻片中0%不满意。
使用细胞学样本进行EGFR检测可避免患者不必要的再次活检,并且在临床上获得的满意率高于NSCLC组织活检的总体满意率。提取的DNA的质量而非数量可能是获得满意结果的更重要决定因素。